Brian earned his Doctor of Pharmacy at Rutgers University and his MBA in Healthcare from George Washington University. He entered the industry as a Medical Science Liaison at Watson Pharmaceuticals in Morristown, New Jersey, where he built the clinical foundation that would anchor every commercial role that followed.

He built his commercial leadership at Boehringer Ingelheim over twelve years, rising through five consecutive Director-level roles across HCP marketing, peer-to-peer digital strategy, key opinion leader and medical education programs, global pipeline marketing across obesity, cardiovascular, renal, and metabolic therapeutic areas, and managed markets strategy. Beginning a Director role in his early thirties was itself a marker of high performance — but the development that happened across those five roles over seven years was the foundation of everything that followed.

He rose to Executive Director of Marketing for Rare Renal at Novartis, then to Vice President and Senior General Manager leading the rare renal business unit — a 250-person organization responsible for the commercialization of iptacopan for IgA nephropathy, PNH, and C3G. In that role he earned the Novartis President's Award as a Top 5 US Leader for a basket of performance including sales results, people development, leadership, and employee retention. He went on to lead global marketing for Beovu in retina and worldwide new products marketing in cardiometabolics at Novartis before transitioning to Director roles at Allergan in women's health and Otsuka in nephrology and rare disease.